Skip to content
StrideSpot

The Zimbabwean Government Turns Down ‘Lopsided’ US Health Aid Agreement Because of Data Fears

Medical funding illustration
The offered US financial assistance was intended for programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a substantial American healthcare agreement valued at $367m (272 million pounds) over five years because of Washington's insistence on sensitive information.

This rejection came to light after a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "skewed".

A government representative has since clarified that the US was demanding access to health data for scientific study and commercial gain but was not willing to share the benefits from any future vaccines.

"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for more dialogue to secure a agreement agreeable to both sides so the country's vital HIV treatment initiative can be sustained.

Wider Implications

This rejection follows a similar case in Kenya, where a high court halted a related health funding agreement after concerns were raised about the security of Kenyans' health data.

After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had administered assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government agreements to boost transparency and accountability.

Based on statements, Sixteen nations in Africa have so far signed these new agreements, representing more than $18.3bn in new funding.

Details of the Rejected Deal

The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to share its biological resources and data for a long time, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that might result from that provided information," his statement read.

"Put simply, our nation would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our people should a future pandemic emerge."

Sovereignty and International Frameworks

He also pointed out that the American exit from the global health body and its pursuit of bilateral deals were undermining frameworks previously established via the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.

"This framework is intended to guarantee that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage further dialogue with our American counterparts on how subsequent collaboration could be arranged in a manner that respects the sovereignty and dignity of both nations."

Health Experts Response

Medical experts expressed it recognised the government's concerns, but suggested that talks should continue given that a large portion of the nation's Aids initiatives depended on external financing.

"If specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group said.

The halted deal underscores the complex debate between receiving crucial international aid and protecting local interests in an ever more interconnected world.

By

Michael Chen

A certified running coach and outdoor enthusiast who shares practical tips and personal experiences to help runners achieve their goals.

StrideSpot

Type to search articles.